The researchers identified 993 neonates (2.6%) who received iNO among 37,909 neonates in the study sample. A total of 971 patients were included in each of the two matched cohorts.
Budesonide used for prevention of bronchopulmonary dysplasia in extremely preterm infants showed no difference in rate of neurodevelopmental disability at two years compared to placebo treated infants.
The researchers found that the rate of inappropriate antibiotic prescribing decreased in control clinics from 14.2 to 11.8% during the post-intervention period (absolute difference, −2.4%).
Two post-hoc analyses have demonstrated efficacy of nintedanib in idiopathic pulmonary fibrosis (IPF), regardless of a patient's disease severity at the start of the trials.
A new review of obstructive sleep apnea (OSA) and potential underlying drug interactions, has identified drugs that exacerbate OSA and should be avoided.
For preterm infants with early respiratory distress, high-flow therapy used as primary support is associated with a higher rate of treatment failure than continuous positive airway pressure (CPAP), according to a study published in the New England Journal of Medicine.
Patients with pacemakers and sleep apnea are at much greater risk for atrial fibrillation, according to a study presented at the annual meeting of the Heart Rhythm Society.
Xlear have announced that their line of xylitol-based products for adults with upper respiratory problems will be available at 1,300 Target stores nationwide.
For patients with obstructive sleep apnea (OSA), initiation of continuous positive airway pressure (CPAP) is associated with a reduction in basal metabolic rate (BMR).
Sleep-disordered breathing (SDB) has a deleterious impact in children, affecting neurocognitive functioning, according to a study published online in the American Journal of Respiratory and Critical Care Medicine.
The period prevalence of acute respiratory distress syndrome (ARDS) is 10.4% in intensive care unit (ICU) admissions, according to a study published online February 22 in the Journal of the American Medical Association to coincide with the Society of Critical Care Medicine's 45th Critical Care Congress.
For patients with severe obstructive sleep apnea under a copayment health care system, obstacles other than finances are primarily responsible for reduced purchase of continuous positive airway pressure (CPAP) devices, according to a study published in the Annals of the American Thoracic Society.
For children with obstructive sleep apnea syndrome (OSAS), early adenotonsillectomy (eAT) is associated with greater weight gain.
There are no significant clinical differences between the use of a breath-actuated nebulizer and a handheld nebulizer for the treatment of wheezing or dyspnea among adults seen in the ER.
For children younger than 3 years with obstructive sleep apnea (OSA), residual OSA is relatively common after adenotonsillectomy (T&A).
After major abdominal surgery, lung-protective ventilation with the use of low tidal volumes and positive end-expiratory pressure is associated with improved clinical outcomes.
A primary care physician's care for sleep apnea is just as good as a specialist center or university setting, according to a new study.
For tracheotomized patients, unassisted breathing through a tracheostomy collar is associated with shorter median weaning time compared to pressure support.
For patients with acute respiratory distress syndrome (ARDS), treatment with high-frequency oscillatory volume (HFOV) does not reduce mortality.
For very premature infants there is no significant difference in death or neurodevelopmental impairment with continuous positive airway pressure (CPAP) versus surfactant; however, lower oxygen-saturation targets cannot be recommended as mortality is still lower with higher oxygen saturation.
Protective ventilation with lower tidal volumes is associated with better clinical outcomes in patients without acute respiratory distress syndrome (ARDS).
In the elderly, untreated severe obstructive sleep apnea (OSA) is associated with an increased risk of cardiovascular death, and adequate treatment with continuous positive airway pressure (CPAP) may reduce this risk.
The American Academy of Pediatrics (AAP) is revising its recommendations for the diagnosis and management of obstructive sleep apnea syndrome (OSAS) in children and adolescents.
For men with obstructive sleep apnea (OSA), treatment with continuous positive airway pressure (CPAP) therapy is associated with an improvement in sexual function and satisfaction, with more robust improvements seen for men with baseline erectile dysfunction (ED).